Several studies have demonstrated that CXCR4 could promote cell proliferation in pulmonary vasculature and some tumor cells via PI3K/Akt and RhoA/ROCK signaling pathway (Wei et al., 2015; Mu et al., 2018; Singh et al., 2020; Wu et al., 2020). Here, RHOA is linked to neoplasm.